Thioridazine reduces resistance of methicillin-resistant Staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump

Malthe M. Kristiansen, Clara Leandro, Diane Ordway, Marta Martins, Miguel Viveiros, Teresa Pacheco, J. Molnár, Jette E. Kristiansen, Leonard Amaral

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Previous studies suggested that the phenothiazine chlorpromazine (CPZ) could reverse or reduce the antibiotic resistance of bacteria. In some areas of the world, the majority of Staphylococcus aureus isolates are now resistant to methicillin, prompting this study to see whether such resistance can be altered by phenothiazine thioridazine (TZ), an agent with equal antibacterial activity, which is free of the severe side-effects associated with chronic administration of CPZ. The results indicated that, whereas methicillin-sensitive strains of Staphylococcus aureus (MSSA) were not rendered more susceptible to oxacillin, resistance to oxacillin by highly-resistant strains (MRSA) could be significantly reduced by sub-inhibitory concentrations of TZ. Reserpine, an inhibitor of efflux pumps, was also shown to reduce the resistance of MRSA strains to oxacillin in a concentration-dependent manner. The phenothiazines have been shown, by others, to inhibit the efflux pumps of bacteria and the mechanism by which MRSA are rendered more susceptible to oxacillin in the presence of TZ is believed to be due to a similar efflux pump.

Original languageEnglish
Pages (from-to)361-366
Number of pages6
JournalIn Vivo
Volume20
Issue number3
Publication statusPublished - May 2006

Fingerprint

Thioridazine
Oxacillin
Methicillin
Reserpine
Methicillin-Resistant Staphylococcus aureus
Pumps
Chlorpromazine
Staphylococcus aureus
Bacteria
Phenothiazines
Methicillin Resistance
Microbial Drug Resistance
Anti-Bacterial Agents
phenothiazine

Keywords

  • Antibiotic resistance
  • Fluoroquinolone resistance
  • Methicillin resistance
  • Phenothiazines
  • Staphylococcus aureus

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kristiansen, M. M., Leandro, C., Ordway, D., Martins, M., Viveiros, M., Pacheco, T., ... Amaral, L. (2006). Thioridazine reduces resistance of methicillin-resistant Staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump. In Vivo, 20(3), 361-366.

Thioridazine reduces resistance of methicillin-resistant Staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump. / Kristiansen, Malthe M.; Leandro, Clara; Ordway, Diane; Martins, Marta; Viveiros, Miguel; Pacheco, Teresa; Molnár, J.; Kristiansen, Jette E.; Amaral, Leonard.

In: In Vivo, Vol. 20, No. 3, 05.2006, p. 361-366.

Research output: Contribution to journalArticle

Kristiansen, MM, Leandro, C, Ordway, D, Martins, M, Viveiros, M, Pacheco, T, Molnár, J, Kristiansen, JE & Amaral, L 2006, 'Thioridazine reduces resistance of methicillin-resistant Staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump', In Vivo, vol. 20, no. 3, pp. 361-366.
Kristiansen MM, Leandro C, Ordway D, Martins M, Viveiros M, Pacheco T et al. Thioridazine reduces resistance of methicillin-resistant Staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump. In Vivo. 2006 May;20(3):361-366.
Kristiansen, Malthe M. ; Leandro, Clara ; Ordway, Diane ; Martins, Marta ; Viveiros, Miguel ; Pacheco, Teresa ; Molnár, J. ; Kristiansen, Jette E. ; Amaral, Leonard. / Thioridazine reduces resistance of methicillin-resistant Staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump. In: In Vivo. 2006 ; Vol. 20, No. 3. pp. 361-366.
@article{12402f30b01c4119865116f6eb3c4558,
title = "Thioridazine reduces resistance of methicillin-resistant Staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump",
abstract = "Previous studies suggested that the phenothiazine chlorpromazine (CPZ) could reverse or reduce the antibiotic resistance of bacteria. In some areas of the world, the majority of Staphylococcus aureus isolates are now resistant to methicillin, prompting this study to see whether such resistance can be altered by phenothiazine thioridazine (TZ), an agent with equal antibacterial activity, which is free of the severe side-effects associated with chronic administration of CPZ. The results indicated that, whereas methicillin-sensitive strains of Staphylococcus aureus (MSSA) were not rendered more susceptible to oxacillin, resistance to oxacillin by highly-resistant strains (MRSA) could be significantly reduced by sub-inhibitory concentrations of TZ. Reserpine, an inhibitor of efflux pumps, was also shown to reduce the resistance of MRSA strains to oxacillin in a concentration-dependent manner. The phenothiazines have been shown, by others, to inhibit the efflux pumps of bacteria and the mechanism by which MRSA are rendered more susceptible to oxacillin in the presence of TZ is believed to be due to a similar efflux pump.",
keywords = "Antibiotic resistance, Fluoroquinolone resistance, Methicillin resistance, Phenothiazines, Staphylococcus aureus",
author = "Kristiansen, {Malthe M.} and Clara Leandro and Diane Ordway and Marta Martins and Miguel Viveiros and Teresa Pacheco and J. Moln{\'a}r and Kristiansen, {Jette E.} and Leonard Amaral",
year = "2006",
month = "5",
language = "English",
volume = "20",
pages = "361--366",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "3",

}

TY - JOUR

T1 - Thioridazine reduces resistance of methicillin-resistant Staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump

AU - Kristiansen, Malthe M.

AU - Leandro, Clara

AU - Ordway, Diane

AU - Martins, Marta

AU - Viveiros, Miguel

AU - Pacheco, Teresa

AU - Molnár, J.

AU - Kristiansen, Jette E.

AU - Amaral, Leonard

PY - 2006/5

Y1 - 2006/5

N2 - Previous studies suggested that the phenothiazine chlorpromazine (CPZ) could reverse or reduce the antibiotic resistance of bacteria. In some areas of the world, the majority of Staphylococcus aureus isolates are now resistant to methicillin, prompting this study to see whether such resistance can be altered by phenothiazine thioridazine (TZ), an agent with equal antibacterial activity, which is free of the severe side-effects associated with chronic administration of CPZ. The results indicated that, whereas methicillin-sensitive strains of Staphylococcus aureus (MSSA) were not rendered more susceptible to oxacillin, resistance to oxacillin by highly-resistant strains (MRSA) could be significantly reduced by sub-inhibitory concentrations of TZ. Reserpine, an inhibitor of efflux pumps, was also shown to reduce the resistance of MRSA strains to oxacillin in a concentration-dependent manner. The phenothiazines have been shown, by others, to inhibit the efflux pumps of bacteria and the mechanism by which MRSA are rendered more susceptible to oxacillin in the presence of TZ is believed to be due to a similar efflux pump.

AB - Previous studies suggested that the phenothiazine chlorpromazine (CPZ) could reverse or reduce the antibiotic resistance of bacteria. In some areas of the world, the majority of Staphylococcus aureus isolates are now resistant to methicillin, prompting this study to see whether such resistance can be altered by phenothiazine thioridazine (TZ), an agent with equal antibacterial activity, which is free of the severe side-effects associated with chronic administration of CPZ. The results indicated that, whereas methicillin-sensitive strains of Staphylococcus aureus (MSSA) were not rendered more susceptible to oxacillin, resistance to oxacillin by highly-resistant strains (MRSA) could be significantly reduced by sub-inhibitory concentrations of TZ. Reserpine, an inhibitor of efflux pumps, was also shown to reduce the resistance of MRSA strains to oxacillin in a concentration-dependent manner. The phenothiazines have been shown, by others, to inhibit the efflux pumps of bacteria and the mechanism by which MRSA are rendered more susceptible to oxacillin in the presence of TZ is believed to be due to a similar efflux pump.

KW - Antibiotic resistance

KW - Fluoroquinolone resistance

KW - Methicillin resistance

KW - Phenothiazines

KW - Staphylococcus aureus

UR - http://www.scopus.com/inward/record.url?scp=33646842666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646842666&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 361

EP - 366

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 3

ER -